Generic Name  | 
        Imatinib + Dovitinib | |
|---|---|---|
IND  | 
               ||
Brand Name (US)  | 
        Gleevec + Dovitinib | |
Manufacturer  | 
        Novartis | |
Drug Type  | 
        ||
Delivery  | 
        Oral | |
Approval Status  | 
        ||
Indications  | 
        ||
Overall Strategy  | 
        KIT Protein + GIST cell based | |
Strategy  | 
        Block KIT + Block blood vessel growth | |
Drug Category  | 
        KIT/PDGFRA inhibitor+ VEGF inhibitor (TKI) | |
Links | 
      |
Trials of this drug | 
      |
  | 
        Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors | 
Trial results | 
      |